Analyzing CRISPR-Cas9 through Genomic Deletions
Background: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a technology used to edit genomes at very high precision. It enables precise editing of genomic loci with a RNA-guided CRISPR associated protein 9 (Cas9) nuclease that can cleave the targeted DNA complementary to a guide RNA (gRNA). Precise gene editing via CRISPR-Cas9 has great potential in treating inherited diseases (e.g., cystic fibrosis) or correcting genetic defects.
Objective: To test the specificity and function of the CRISPR-Cas9 in a proof-of-principle experiment, we used two human Emx1 (hEmx1) gene-specific gRNA sequences (3.1+4.1) to guide the Cas9 enzyme for the deletion of the targeted region in human 293AD cells.
Analyzing CRISPR-Cas9 through Genomic Deletions Read More »



